Picture of Halozyme Therapeutics logo

HALO — Halozyme Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Live Markets: Healthcare leads Europe lower

* 
      STOXX 600 down 0.6%
    

        * 
      Healthcare lags
    

        * 
      GSK, Sanofi fall on RFK Jr. nomination
    

        * 
      Wall St futures lower
    

  
Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You
can share your thoughts with us at     
    
    HEALTHCARE LEADS EUROPE LOWER
    A fall in healthcare stocks is leading major European stock indexes lower on Friday, with
vaccine markers hit particularly hard after Trump nominated RFK Jr. to lead the top U.S. health
body. 
    Kennedy has been criticized for making false medical claims, including that vaccines are
linked to autism.
    European-listed vaccine makers - GSK  GSK.L , Sanofi  SASY.PA  and Biontech  22UAy.DE  among
others - are lower by between 3.3%-9%. 
    Overall, the healthcare subsector  .SXDP  is underperforming, down 2.2%, compared to a 0.7%
drop for the broader STOXX 600  .STOXX .
    The index is on track to end a choppy week down by about 0.5%. 
    Switzerland's SMI  .SSMI , which has a heavy weighting towards healthcare stocks, is the
worst performing major bourse in Europe, falling about 1%. 
    In other corporate news, Evotec  EVTG.DE  shares are surging almost 18% after the company
received a takeover approach from Halozyme Therapeutics  HALO.O . 
    Here's your opening snapshot: 
    (Samuel Indyk)
    *****

    FRIDAY'S OTHER LIVE MARKETS POSTS:
    EUROPEAN STOCK FUTURES HEAD SOUTH CLICK HERE
        CHINESE CONSUMERS SPEND MORE, JUST NOT ON PROPERTY 
    CLICK HERE
  
        
  

    <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
China's mixed October data keeps stimulus calls alive    https://reut.rs/3YPXD6v
European shares mostly lower    https://reut.rs/3AJ3t1h
    ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Recent news on Halozyme Therapeutics

See all news